Dark
Light
System
Security
BRAINSTORM CELL THERAPEUTICS
BRAINSTORM CELL THERAPEUTICS. Institutional holdings reported to the SEC.

Institutional Holders (2016Q2)
Portfolio Summary: 23 Institutional holders with a total value of $3,930,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 DAY & ENNIS, LLC 4 0 0.00%
2 CITIGROUP INC 370 1,000 0.03%
3 US BANCORP \DE\ 275 1,000 0.03%
4 Creative Planning 1,000 2,000 0.05%
5 ADVISOR GROUP, INC. 1,500 3,000 0.08%
6 MSI Financial Services Inc 1,200 3,000 0.08%
7 TCI Wealth Advisors, Inc. 1,100 3,000 0.08%
8 BlackRock Investment Management, LLC 3,003 7,000 0.18%
9 UBS Group AG 5,385 13,000 0.33%
10 BANK OF AMERICA CORP /DE/ 10,053 24,000 0.61%
11 GUARDIAN CAPITAL ADVISORS LP 10,000 25,000 0.64%
12 HighTower Advisors, LLC 10,766 26,000 0.66%
13 ROYAL BANK OF CANADA 11,533 28,000 0.71%
14 M&T BANK CORP 13,333 32,000 0.81%
15 Bank of New York Mellon Corp 18,228 44,000 1.12%
16 Psagot Value Holdings Ltd. 22,715 55,000 1.40%
17 NORTHERN TRUST CORP 23,043 56,000 1.42%
18 BlackRock Institutional Trust Company, N.A. 24,789 60,000 1.53%
19 BlackRock Fund Advisors 41,811 101,000 2.57%
20 GEODE CAPITAL MANAGEMENT, LLC 61,269 147,000 3.74%
21 PERCEPTIVE ADVISORS LLC 400,000 964,000 24.53%
22 SABBY MANAGEMENT, LLC 476,719 1,149,000 29.24%
23 VANGUARD GROUP INC 491,867 1,186,000 30.18%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.